(Q30409533)

English

Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

3

object named as

Jaffer A Ajani

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Christopher G. Willett

11

object named as

Christopher G Willett

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

author name string

Leonard L Gunderson

1

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Jennifer Moughan

2

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

John E Pedersen

4

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Kathryn A Winter

5

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Al B Benson

6

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Charles R Thomas

7

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Robert J Mayer

8

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Michael G Haddock

9

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Tyvin A Rich

10

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

language of work or name

0 references

publication date

10 September 2013

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

87

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

638-645

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

Anal cancer: an examination of radiotherapy strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

Revised TN categorization for colon cancer based on national survival outcomes data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

US intergroup anal carcinoma trial: tumor diameter predicts for colostomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

20 June 2018

Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

26 November 2018

Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

26 November 2018

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3938865

26 November 2018

Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research

1 reference

https://pubmed.ncbi.nlm.nih.gov/24035327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

https://pubmed.ncbi.nlm.nih.gov/24035327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314

1 reference

https://pubmed.ncbi.nlm.nih.gov/24035327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24035327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24035327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors and patterns of recurrence after definitive chemoradiation for anal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24035327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2013.07.035

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30409533&oldid=2191341379"